N
NECTAR LIFESCIENCE LTD. (UNIT VI)
Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company offers contract research and manufacturing services, including process development and optimization, process scale up and validation, preparation and international submission of drug master files and certificates of suitability, multi kilo pilot plant production, bulk production, and chiral resolution; and chemical and analytical development, as well as analytical, manufacturing, and engineering consulting services. Its active pharmaceutical ingredients and intermediates comprise cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil, cefdinir, ceftriaxone sodium, cefotaxime sodium, cefuroxime sodium, ceftazidime, cefepime HCl, cephalothin, cefazolin sodium, cefprozil, cefoperzone sodium, cefpirome sulphate, and cefoxitin sodium. The company also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, it provides a range of diagnostics products; empty hard gelatin capsules; and menthol products. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.
Country/Area ：India
Company Email ：hr@neclife.com
Industry ：RetailDrug Stores & Pharmacies
Company address ：sco 38-39 Sector 9d, Sector, Chandigarh, 160009, India
Company website ：*****
Company phone ：+91 1723047777
Established ：1995
Company Revenue ：$213,323,000
Number of employees ：2000
SIC Code ：28283
NAICS Code ：32325
Company News
ZEE BIZ EXCLUSIVE: Promoters may sell entire stake of Nectar Lifesciences; deal likely to happen ...
Jul 12, 2021
In a conversation with Zee Business Managing Editor Anil Singhvi, Swati Khandelwal, Executive Editor at Zee Business informed that according to the sources the promoters of Nectar Lifesciences are planning to sell their shares of the company. Get more Markets News and Business News on Zee Business.
Jul 12, 2021
Natural Menthol Market to Set New Growth Story : BASF, Symrise, Nantong Menthol Factory, Nectar LifesciencesApr 14, 2020
Edison, NJ -- (SBWIRE) -- 04/14/2020 -- Global Natural Menthol Market Report from Advance Market Analytics (AMA) covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market. The market characteristics section of the report defines and explains the market. The market size section gives the electronic equipment market revenues, covering both the historic growth of the market and forecasting the futur
Apr 14, 2020The Global Empty Capsules Market is Projected to Grow at a CAGR of 7.4% from 2018 to 2023Oct 31, 2018
NEW YORK, Oct. 30, 2018 /PRNewswire/ -- The Global Empty Capsules Market is Projected to Grow at a CAGR of 7.4% from 2018 to 2023. Read the full report: https://www.reportlinker.com/p03841064 The empty capsules market is projected to reach USD 2.79 billion by 2023 from an estimated USD...
Oct 31, 2018Empty Capsules Market Worth $2.79 Billion by 2023 - Exclusive Report by MarketsandMarkets™Oct 23, 2018
CHICAGO, October 23, 2018 /PRNewswire/ -- According to the new market research report "Empty Capsules Market by Type ((Gelatin - Porcine, Bovine, Bone Meal), (HPMC, Pullulan)), Functionality (Sustained-release, Delayed-release), Application (Antibiotics, Vitamins, Antacids), End User...
Oct 23, 2018Web Summary
Q1: What is the address of Nectar Lifesciences Limited's head office?
A1: The address of Nectar Lifesciences Limited's head office is SCO 38-39, Sector 9-D, Chandigarh – 160009.
Q2: What are some of the business areas that Nectar Lifesciences Limited operates in?
A2: Nectar Lifesciences Limited operates in various business areas including APIs, Formulations, Empty Hard Gelatin Capsules, CSR, EHS, and Investor Relations.
Q3: Who is the Chief Executive Officer (CEO) of Nectar Lifesciences Limited?
A3: The CEO of Nectar Lifesciences Limited is Mr. Amit Chadah.
Q4: What is the contact email address for investor-related queries?
A4: The contact email address for investor-related queries is cs@neclife.com, which can be directed to Neha Vaishnav, the Compliance Officer (CO).
Q5: How many countries does Nectar Lifesciences Limited have a strong hold of API & Formulation business in?
A5: Nectar Lifesciences Limited has a strong hold of API & Formulation business in almost 45 countries of the world.
Q6: What is the total value of the World Pharmaceutical Market, according to Nectar Lifesciences Limited?
A6: The current value of the World Pharmaceutical Market is USD 1.2 Trillion, with First to Fifth Gen Antibiotics constituting $100 Billion.
Q7: What is the share of Cephalosporins in the World Pharmaceutical Market, as per Nectar Lifesciences Limited?
A7: Cephalosporins hold a share of $21 Billion in the World Pharmaceutical Market, providing Nectar an addressable market of nearly $13 Billion.
Q8: How many State-of-the-Art manufacturing facilities does Nectar Lifesciences Limited have across Punjab and Himachal Pradesh?
A8: Nectar Lifesciences Limited has 11 State-of-the-Art manufacturing facilities spread across the States of Punjab and Himachal Pradesh.
A1: The address of Nectar Lifesciences Limited's head office is SCO 38-39, Sector 9-D, Chandigarh – 160009.
Q2: What are some of the business areas that Nectar Lifesciences Limited operates in?
A2: Nectar Lifesciences Limited operates in various business areas including APIs, Formulations, Empty Hard Gelatin Capsules, CSR, EHS, and Investor Relations.
Q3: Who is the Chief Executive Officer (CEO) of Nectar Lifesciences Limited?
A3: The CEO of Nectar Lifesciences Limited is Mr. Amit Chadah.
Q4: What is the contact email address for investor-related queries?
A4: The contact email address for investor-related queries is cs@neclife.com, which can be directed to Neha Vaishnav, the Compliance Officer (CO).
Q5: How many countries does Nectar Lifesciences Limited have a strong hold of API & Formulation business in?
A5: Nectar Lifesciences Limited has a strong hold of API & Formulation business in almost 45 countries of the world.
Q6: What is the total value of the World Pharmaceutical Market, according to Nectar Lifesciences Limited?
A6: The current value of the World Pharmaceutical Market is USD 1.2 Trillion, with First to Fifth Gen Antibiotics constituting $100 Billion.
Q7: What is the share of Cephalosporins in the World Pharmaceutical Market, as per Nectar Lifesciences Limited?
A7: Cephalosporins hold a share of $21 Billion in the World Pharmaceutical Market, providing Nectar an addressable market of nearly $13 Billion.
Q8: How many State-of-the-Art manufacturing facilities does Nectar Lifesciences Limited have across Punjab and Himachal Pradesh?
A8: Nectar Lifesciences Limited has 11 State-of-the-Art manufacturing facilities spread across the States of Punjab and Himachal Pradesh.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
